SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-17-009104
Filing Date
2017-02-14
Accepted
2017-02-14 13:04:10
Documents
1
Group Members
VEF MANAGEMENT IV, LLCVENROCK ENTREPRENEURS FUND IV, L.P.VENROCK MANAGEMENT IV, LLCVENROCK PARTNERS MANAGEMENT, LLCVENROCK PARTNERS, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a17-4300_1sc13ga.htm SC 13G/A 211316
  Complete submission text file 0001104659-17-009104.txt   213020
Mailing Address 3340 HILLVIEW AVENUE PALO ALTO CA 94304
Business Address 3340 HILLVIEW AVENUE PALO ALTO CA 94304 650-475-3734
VENROCK ASSOCIATES IV L P (Filed by) CIK: 0001277997 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Subject) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88741 | Film No.: 17606164
SIC: 2834 Pharmaceutical Preparations